RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Biolight Life Sciences Stock

Biolight Life Sciences ROCE 2024

Biolight Life Sciences ROCE

-0.36

Ticker

BOLT.TA

ISIN

IL0010952237

In 2024, Biolight Life Sciences's return on capital employed (ROCE) was -0.36, a 84.25% increase from the -0.19 ROCE in the previous year.

Biolight Life Sciences Aktienanalyse

What does Biolight Life Sciences do?

Biolight Life Sciences Ltd is a global company specializing in the development, production, and marketing of medical devices and products. It was founded in China in 1993 and has since relocated its headquarters to Israel. Biolight has evolved from a small company to a leading provider of medical devices and products that help improve patient treatment and optimize healthcare. The company's business model is based on selling medical devices and products used in diagnosis, monitoring, and treatment of patients. It continually strives to improve its products through research and development to enhance healthcare worldwide. Biolight believes that cooperative technologies and services can create synergistic value that benefits patients. Its various divisions include monitoring and diagnostic devices, cardiology products, and emergency medicine products. Biolight offers a wide range of products to ensure quality healthcare. Its monitoring and diagnostic devices measure various physiological parameters such as blood pressure, heart rate, respiration, oxygen saturation, and temperature. The cardiology products are tailored to the needs of heart patients and include EKG devices, long-term EKG systems, and Holter devices. The emergency medicine products treat life-threatening conditions such as heart attacks, strokes, and respiratory distress, thereby saving lives. To ensure a high-quality healthcare system, it is essential for medical devices and products to meet the highest standards. Biolight is aware of this and is committed to offering products that comply with the strictest international quality standards such as ISO 13485, CE, and FDA. Biolight has a broad global presence with branches and subsidiaries in numerous countries such as the USA, China, India, Germany, Spain, and France. This global presence enables the company to understand and meet the needs of patients and medical personnel in different parts of the world. Biolight also collaborates with partners and customers to further improve its products and services and meet market demands. Overall, Biolight has made a sustainable contribution to improving healthcare. Through its continuous research and development, products and services, and global presence, the company has established itself as a key player in the medical technology industry. By working with partners and customers, Biolight can contribute to ensuring that patients worldwide have access to the best healthcare. Biolight Life Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Biolight Life Sciences's Return on Capital Employed (ROCE)

Biolight Life Sciences's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Biolight Life Sciences's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Biolight Life Sciences's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Biolight Life Sciences’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Biolight Life Sciences stock

What is the ROCE (Return on Capital Employed) of Biolight Life Sciences this year?

The ROCE of Biolight Life Sciences is -0.36 undefined this year.

How has the ROCE (Return on Capital Employed) of Biolight Life Sciences developed compared to the previous year?

The ROCE of Biolight Life Sciences has increased by 84.25% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Biolight Life Sciences?

A high Return on Capital Employed (ROCE) indicates that Biolight Life Sciences has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Biolight Life Sciences?

A low ROCE (Return on Capital Employed) can indicate that Biolight Life Sciences has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Biolight Life Sciences impact the company?

An increase in the ROCE of Biolight Life Sciences can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Biolight Life Sciences affect the company?

A decrease in ROCE of Biolight Life Sciences can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Biolight Life Sciences?

Some factors that can affect Biolight Life Sciences's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Biolight Life Sciences so important for investors?

The ROCE of Biolight Life Sciences is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Biolight Life Sciences take to improve the ROCE?

To improve the ROCE, Biolight Life Sciences can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Biolight Life Sciences pay?

Over the past 12 months, Biolight Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biolight Life Sciences is expected to pay a dividend of 0 ILS.

What is the dividend yield of Biolight Life Sciences?

The current dividend yield of Biolight Life Sciences is .

When does Biolight Life Sciences pay dividends?

Biolight Life Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biolight Life Sciences?

Biolight Life Sciences paid dividends every year for the past 0 years.

What is the dividend of Biolight Life Sciences?

For the upcoming 12 months, dividends amounting to 0 ILS are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biolight Life Sciences located?

Biolight Life Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biolight Life Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biolight Life Sciences from 12/24/2024 amounting to 0 ILS, you needed to have the stock in your portfolio before the ex-date on 12/24/2024.

When did Biolight Life Sciences pay the last dividend?

The last dividend was paid out on 12/24/2024.

What was the dividend of Biolight Life Sciences in the year 2023?

In the year 2023, Biolight Life Sciences distributed 0 ILS as dividends.

In which currency does Biolight Life Sciences pay out the dividend?

The dividends of Biolight Life Sciences are distributed in ILS.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Biolight Life Sciences

Our stock analysis for Biolight Life Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biolight Life Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.